Large volume fluid drainage without albumin infusion associated with complications in refractory ascites

Written By :  Niveditha Subramani
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-07-18 14:30 GMT   |   Update On 2023-07-19 10:39 GMT
Advertisement

Paracentesis is a common procedure performed to obtain a small sample of or drain ascitic fluid for both diagnostic or therapeutic purposes for ascites. Ascites is characterized by too much fluid build up in abdomen that often happens in people who have cirrhosis (scarring) of the liver.

Association of low-volume paracentesis of less than 5 L with complications in patients with ascites remains unclear, and individuals with cirrhosis and refractory ascites (RA) treated with devices like Alfapump or tunneled-intraperitoneal catheters perform daily low-volume drainage without albumin substitution.

Advertisement

In a cohort study of 250 patients with refractory ascites, drainage of 1.5 L/d or more was associated with a higher incidence of hyponatremia or acute kidney injury than drainage of less than 1.5 L/d. Drainage of 1.5 L/d or more was also linked to more complications, while this was not the case in those with drainage less than 1.5 L/d. The findings of the study are published in JAMA Network.

The researchers included retrospective cohort study of patients with liver cirrhosis, RA, and a contraindication for a transjugular intrahepatic portosystemic shunt who received either device implantation or standard of care (SOC; ie, repeated large-volume paracentesis with albumin infusion), and were hospitalized between 2012 and 2020 were included. Data were analyzed from April to October 2022. The primary end points were 90-day incidence of hyponatremia and AKI. Propensity score matching was performed to match and compare patients with devices and higher or lower drainage volumes to those who received SOC.

The key findings of the study are

• A total of 250 patients with RA receiving either device implantation (179 patients; 125 male; 54 female) or SOC (71 patients; 41 male; 20 female) were included in this study.

• A cutoff of 1.5 L/d or more was identified to estimate hyponatremia and AKI in the included patients with devices. Drainage of 1.5 L/d or more was associated with hyponatremia and AKI, even after adjusting for various confounders (hazard ratio [HR], 2.17 [95% CI, 1.24-3.78]; P = .006; HR, 1.43 [95% CI, 1.01-2.16]; P = .04, respectively).

• Moreover, patients with taps of 1.5 L/d or more and less than 1.5 L/d were matched with patients receiving SOC.

• Those with taps of 1.5 L/d or more had a higher risk of hyponatremia and AKI compared with those receiving SOC (HR, 1.67 [95% CI, 1.06-2.68]; P = .02 and HR, 1.51 [95% CI, 1.04-2.18]; P = .03), while patients with drainage of less than 1.5 L/d did not show an increased rate of complications compared with those receiving SOC.

Researchers concluded that “In this cohort study, clinical complications in patients with RA performing low-volume drainage without albumin infusion were associated with the daily volume drained. Based on this analysis, physicians should be cautious in patients performing drainage of 1.5 L/d or more without albumin infusion.”

Reference: Tergast TL, Griemsmann M, Stockhoff L, et al. Daily Low-Volume Paracentesis and Clinical Complications in Patients With Refractory Ascites. JAMA Netw Open. 2023;6(7):e2322048. doi:10.1001/jamanetworkopen.2023.22048.

Tags:    
Article Source : JAMA Network

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News